Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Transcatheter Mitral Valve Market: By Product Type, By Distribution Channel, and Geography
Transcatheter Mitral Valve Market: By Product Type, By Distribution Channel, and Geography
Transcatheter Percutaneous Mitral Valve Market size was valued at US$ 5.7 billion in 2023 and is poised to grow at CAGR 6.4% from 2024-2030. report gives a comprehensive outlook on butyric acid derivatives across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on gives historical, current, and future market sizes (US$ Mn) on the basis of product, animal feed and region. This report studies global transcatheter (percutaneous) mitral valve market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).
Key stakeholders of the global butyric acid derivatives market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged. Transcatheter (percutaneous) mitral valve is used to treat mitral regurgitation (MR). Mitral valve disease is the second most common valvular heart disease in adults. MR is classified as either primary (degenerative) or secondary (functional). Primary MR from degenerative valve disease is due to a primary disruption of the mitral valve apparatus from either prolapsed or flail leaflets. Secondary MR on the other hand is due to remodeling of the left ventricle resulting inappropriate coaptation of the mitral leaflets. Trans catheter heart valve implantation procedure helps in replacing the heart valve with prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation. This increases survival rate of patients and helps in reducing severe degenerative aortic stenosis.
Study Period
2024-2030Base Year
2023CAGR
6.4%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Increase in the prevalence of cardiac disorders and increasing aging population are expected to drive the market. The increasing demand for less invasive procedure for high risk patients, severe aortic stenosis disorder and growing prevalence of mitral regurgitation are expected to drive the growth of Transcatheter (percutaneous) mitral valve market. Furthermore, conditions like speedy recovery, shorter span of time required for the patient to stay in the hospital are favoring the implantation of the transcatheter (percutaneous) mitral valve implantation. However, the high costs of the transcatheter heart valves, risk involved in the procedure such as improper positioning of the implant and device related issues such as product recalls by the manufacturers are expected to hamper the growth of transcatheter (percutaneous) mitral valve market.
North America market is growing at unprecedented rate due to increase in the prevalence of cardiac disorders and increasing incidences of mitral valve disorders. The increasing geriatric population, high number of cases of congenital heart defects which is driving the growth of the transcatheter (percutaneous) mitral valve market in this region. The improving technological advancements and rising government funds are expected to drive the market in Europe. Furthermore, in emerging countries of Asia, increasing focus on investigational product and awareness about the treatment procedures among the patient pool is driving the transcatheter (percutaneous) mitral valve market in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 5.7 billion |
|
Market CAGR |
6.4% |
|
By Product Type |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Transcatheter Mitral Valve Market is expected to reach US$ 3.2 Billion by 2029.
| 1.Executive Summary |
| 2.Global Transcatheter (Percutaneous) Mitral Valve Market Introduction |
| 2.1.Global Transcatheter (Percutaneous) Mitral Valve Market - Taxonomy |
| 2.2.Global Transcatheter (Percutaneous) Mitral Valve Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3.Global Transcatheter (Percutaneous) Mitral Valve Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Transcatheter (Percutaneous) Mitral Valve Market Analysis, 2019-2023 and Forecast 2024-2030 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Transcatheter (Percutaneous) Mitral Valve Market By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 5.1. Transfemoral implantation |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Transapical implantation |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Transcatheter (Percutaneous) Mitral Valve Market By Distribution Channel, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Cardiac care centers |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Transcatheter (Percutaneous) Mitral Valve Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Transcatheter (Percutaneous) Mitral Valve Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Transfemoral implantation |
| 8.1.2.Transapical implantation |
| 8.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.Cardiac care centers |
| 8.2.3.Others |
| 8.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Transcatheter (Percutaneous) Mitral Valve Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Transfemoral implantation |
| 9.1.2.Transapical implantation |
| 9.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.Cardiac care centers |
| 9.2.3.Others |
| 9.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 9.3.7. |
| 10.Asia Pacific (APAC) Transcatheter (Percutaneous) Mitral Valve Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Transfemoral implantation |
| 10.1.2.Transapical implantation |
| 10.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.Cardiac care centers |
| 10.2.3.Others |
| 10.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Transcatheter (Percutaneous) Mitral Valve Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Transfemoral implantation |
| 11.1.2.Transapical implantation |
| 11.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.Cardiac care centers |
| 11.2.3.Others |
| 11.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Transcatheter (Percutaneous) Mitral Valve Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Transfemoral implantation |
| 12.1.2.Transapical implantation |
| 12.2. Distribution Channel Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.Cardiac care centers |
| 12.2.3.Others |
| 12.3. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Boston Scientific Corporation (U.S) |
| 13.2.2.Abbott Laboratories (U.S) |
| 13.2.3.Edwards Lifesciences Corporation |
| 13.2.4.Micro Interventional Devices (U.S) |
| 13.2.5.Neochord Inc. (U.S) |
| 13.2.6.Medtronic, Inc. (U.S) |
| 13.2.7.Jude Medical, Inc. (U.S) |
| 13.2.8.JenaValve Technology (U.S) |
| 13.2.9.Livanova Plc, (U.K) |
| 13.2.10.Colibri Heart Valve, Llc. (U.S) |
| 13.2.11.Neovasc (Canada) |
| 13.2.12.Biotronik SE & Co. KG (Germany) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.